Stock was trading higher on takeover speculation. If their pipeline drugs are worth less now in the open market, why would any major biotech make a play for this company. The stock will again trade lower until product news becomes public. Cempra is in the same boat. Ticker cemp.
News 
Market Data 
Discover 
